AU2002228726A1 - Alkynyl amides and their therapeutic applications - Google Patents

Alkynyl amides and their therapeutic applications

Info

Publication number
AU2002228726A1
AU2002228726A1 AU2002228726A AU2872602A AU2002228726A1 AU 2002228726 A1 AU2002228726 A1 AU 2002228726A1 AU 2002228726 A AU2002228726 A AU 2002228726A AU 2872602 A AU2872602 A AU 2872602A AU 2002228726 A1 AU2002228726 A1 AU 2002228726A1
Authority
AU
Australia
Prior art keywords
therapeutic applications
alkynyl amides
alkynyl
amides
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002228726A
Other languages
English (en)
Inventor
Youssef L Bennani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of AU2002228726A1 publication Critical patent/AU2002228726A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/12Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/09Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an acyclic unsaturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU2002228726A 2000-11-01 2001-10-31 Alkynyl amides and their therapeutic applications Abandoned AU2002228726A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70377100A 2000-11-01 2000-11-01
US09/703,771 2000-11-01
PCT/US2001/045704 WO2002036546A2 (fr) 2000-11-01 2001-10-31 Amides d'alkynyle et leurs applications therapeutiques

Publications (1)

Publication Number Publication Date
AU2002228726A1 true AU2002228726A1 (en) 2002-05-15

Family

ID=24826711

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002228726A Abandoned AU2002228726A1 (en) 2000-11-01 2001-10-31 Alkynyl amides and their therapeutic applications

Country Status (8)

Country Link
EP (1) EP1330429A2 (fr)
JP (1) JP4115835B2 (fr)
AU (1) AU2002228726A1 (fr)
CA (1) CA2427560C (fr)
MX (1) MXPA03003926A (fr)
PE (1) PE20020575A1 (fr)
UY (1) UY26997A1 (fr)
WO (1) WO2002036546A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005046659A2 (fr) * 2003-11-12 2005-05-26 Nps Pharmaceuticals, Inc. Traitement de la migraine comportant des composes d'isovaleramide et des agonistes de la serotonine
DE102005062987A1 (de) * 2005-12-28 2007-07-05 Grünenthal GmbH Substituierte Propiolsäureamide und ihre Verwendung zur Herstellung von Arzneimitteln

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585358A (en) 1993-07-06 1996-12-17 Yissum Research Development Corporation Of The Hebrew University Of Jerusalem Derivatives of valproic acid amides and 2-valproenoic acid amides, method of making and use thereof as anticonvulsant agents

Also Published As

Publication number Publication date
WO2002036546A3 (fr) 2002-10-10
UY26997A1 (es) 2002-07-31
MXPA03003926A (es) 2004-05-24
EP1330429A2 (fr) 2003-07-30
JP2004532804A (ja) 2004-10-28
CA2427560A1 (fr) 2002-05-10
JP4115835B2 (ja) 2008-07-09
WO2002036546A2 (fr) 2002-05-10
PE20020575A1 (es) 2002-06-25
CA2427560C (fr) 2010-12-07

Similar Documents

Publication Publication Date Title
AU2002234643A1 (en) Amphoteric liposomes and the use thereof
EP1367060A4 (fr) Derives glucopyranosyloxybenzylbenzene et leur utilisation medicale
EP1364957A4 (fr) Derives de glycopyranosyloxypyrazole et utilisation medicinale de ceux-ci
EP1364958A4 (fr) Derives de glycopyranosyloxypyrazole et utilisation medicinale de ceux-ci
HUP0302471A3 (en) Pyrrolcarboxamides and pyrrolcarbothioamides and their agrochemical uses
AU3620600A (en) Skin-marking devices and their use
IL152705A0 (en) Anthranyl amides and their use as medicaments
AU7240201A (en) Aza- and polyazanthranyl amides and their use as medicaments
AU2002323743A1 (en) Substituted amides and pest controllers
AU2001213042A1 (en) Kneading device and forming device
AU4196801A (en) Chordin-like-2 molecules and uses thereof
AU2002211717A1 (en) Stresscopins and their uses
IL154553A0 (en) Urocortin-iii and uses thereof
AU2002227247A1 (en) Biofilm therapy process and elements
AU2001264273A1 (en) Amide compounds and use thereof
GB0115780D0 (en) Therapeutic molecules and uses thereof
AU2002228726A1 (en) Alkynyl amides and their therapeutic applications
GB0018887D0 (en) Compound and their therapeutic use
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
AU2001234180A1 (en) Benzamide derivative and use thereof
AUPQ884500A0 (en) Novel therapeutic molecules and uses therefor - III
EP1367123A4 (fr) Neurotonine et utilisation
AU2002321141A1 (en) Pyrimidinoxyalkylpiperazines and their therapeutic use
GB0122246D0 (en) Immunotoxins and their therapeutic application
AU2001277519A1 (en) Bio-probes and use thereof